arrow
H

Habib Yaribeygi

Semnan University of Medical Sciences
H指数:44
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adding empagliflozin to ongoing metformin improves metabolic profile, tg-g and fib-4 indexes and liver function tests in type 2 diabetic patients with NAFLDS, a clinical trial

将恩格列净添加到正在进行的二甲双胍治疗中,可改善2型糖尿病合并NAFLDS患者的代谢状况、TG-G和Fib-4指数以及肝功能检查结果,一项临床试验。

2025-08-250
PRE
Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines’ levels in patients with type 2 diabetes, a randomized double-blinded clinical trial

将西格列汀添加到持续使用的二甲双胍中,可通过正常化炎症细胞因子水平来改善2型糖尿病患者的代谢状况和胰腺功能,一项随机双盲临床试验。

2025-07-260
PRE
Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits

钠-葡萄糖协同转运蛋白2抑制剂和肾素-血管紧张素-醛固酮系统,可能的细胞相互作用和益处

2024-10-010
PRE
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI